Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 17 EP applications Olivia Aline Furstoss has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11738415

PROCESS FOR REMOVING ADVENTITIOUS AGENTS DURING THE PRODUCTION OF A VIRUS IN CELL CULTURE

IPC classification:
C12N 7/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13708142

IMMUNOLOGICALLY USEFUL ARGININE SALTS

IPC classification:
A61K 31/4375, A61P 37/04, C07D 471/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP14758351

LARGE SCALE PRODUCTION OF VIRUSES IN CELL CULTURE

IPC classification:
A61K 39/145, C12N 7/00
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12704573

ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

IPC classification:
A61K 9/107, A61K 31/4375, A61K 47/26, A61K 47/32, A61K 47/44
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP14789550

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14795571

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16164271

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

IPC classification:
A61K 9/16, A61K 39/385, A61K 39/39, A61P 31/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15715431

LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY

IPC classification:
A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15716137

IMMUNOGENIC LIPOSOMAL FORMULATION

IPC classification:
A61K 9/127, A61K 31/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709964

OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION

IPC classification:
A61K 9/107, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16190246

LIPIDATED OXOADENINE DERIVATIVES

IPC classification:
A61K 31/52, A61K 31/522, A61P 37/04, C07F 9/6561
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15791768

MAMMALIAN CELLS EXPRESSING CYTOMEGALOVIRUS ANTIGENS

IPC classification:
A61K 39/245, C07K 14/005, C12N 5/071
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15797460

ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/522, A61P 31/00, A61P 35/00, A61P 37/08, C07D 473/18
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15816413

A METHOD FOR A LARGE SCALE VIRUS PURIFICATION

IPC classification:
C12N 7/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16702210

CYTOMEGALOVIRUS ANTIGENS AND USES THEREOF

IPC classification:
A61K 39/245, C07K 14/005, C07K 16/08
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP16702211

CMV ANTIGENS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/245, C07K 14/005, C07K 16/08
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature